Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology
Drug Discovery Today
JANUARY 12, 2021
Exploratory research project aims to develop novel protein expression systems via cell reprogramming
Drug Discovery Today
JANUARY 12, 2021
Exploratory research project aims to develop novel protein expression systems via cell reprogramming
Chemical Biology and Drug Design
DECEMBER 15, 2023
To identify new lead compounds with potential anticancer properties for further optimization, in vitro assays combined with in-silico target fishing and docking have been used to identify and further map out the antiproliferative and potential mode of action of molecules from a small library of compounds previously prepared in our laboratory.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Codon
DECEMBER 10, 2023
The Higgs boson was discovered at CERN, a sprawling particle physics laboratory that cost more than $10 billion to build. Predictive models for biology will span all scales, from individual proteins to the culture conditions in which cells grow. A predictive model for sequence-to-expression would raise the “hit” rates.
Codon
DECEMBER 10, 2023
The Higgs boson was discovered at CERN, a sprawling particle physics laboratory that cost more than $10 billion to build. Predictive models for biology will span all scales, from individual proteins to the culture conditions in which cells grow. A predictive model for sequence-to-expression would raise the “hit” rates.
Drug Target Review
JANUARY 26, 2024
Researchers from Columbia University and the US Department of Energy (DOE)’s Brookhaven National Laboratory have elucidated a method to produce large quantities of the receptor that the SARS-CoV-2 spike protein uses to bind to the surface of human cells.
The Pharma Data
JANUARY 16, 2021
Etta Biotech”), to set up a high titer transient protein expression platform for high quality protein production using JS Bio’s transient transfection media. JS Bio becomes the exclusive cell culture supplier for Etta Biotech’s transient transfection high titer protein expression platform.
PPD
OCTOBER 12, 2023
These treatments use a vector to introduce the desired nucleic acid code to replace or modify protein expression or use cells to alter/restore a specific cell type. In addition, laboratories should be positioned to have an agile response to rapidly adopt any new methods once regulatory guidance is published.
Let's personalize your content